GSP Crop Science reported unaudited Q3 FY26 standalone and consolidated results with nine-month revenue of ₹1,114 crores and a 32% YoY EBITDA growth to ₹153 crores.
Management highlighted a strategy centered on patented products, which now contribute 20% of revenue and command a 20-25% premium over generic margins.
The company increased product prices by 10-15% from April 1st to pass on rising raw material and logistics costs linked to Middle East conflict and crude oil prices.
Future growth is targeted 5-7% higher than the last three years, supported by new product launches and expansion into Brazil via a newly established subsidiary.